Farxiga 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FQ9WU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,355
Award facts
- Contract value 100% obligated
- $39,355.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,355.36 delivery order to AmerisourceBergen Drug Corp for the supply of FARXIGA 10 mg tablets (30-count units) under a firm fixed price contract type. This non-set-aside award was issued on November 18, 2025, with an ultimate completion date of November 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. FARXIGA is a pharmaceutical product used in the treatment of heart failure and chronic kidney disease, representing part of the broader federal medical procurement requirements that the Defense Logistics Agency fulfills for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceuticals and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp has demonstrated its capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains and delivery order values.
Quick answers
Who was awarded contract SPE2DR26FQ9WU?
SPE2DR26FQ9WU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FQ9WU worth?
The government has obligated $39,355 on SPE2DR26FQ9WU.
Is contract SPE2DR26FQ9WU an order under another contract?
Yes. SPE2DR26FQ9WU is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FQ9WU competed?
The extent of competition for SPE2DR26FQ9WU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award